Morgan Stanley restated their equal weight rating on shares of Oscar Health (NYSE:OSCR – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. They currently have a $5.00 target price on the stock. Separately, Bank of America raised Oscar Health from an underperform rating to a neutral rating and increased […]